Vaginal Cancer Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Clinical Trials

T Cell Receptor Immunotherapy Targeting HPV-16 E6 for HPV-Associated Cancers
Conditions:   Vaginal Cancer;   Cervical Cancer;   Anal Cancer;   Penile Cancer;   Oropharyngeal CancerInterventions:   Drug: Fludarabine;   Drug: Cyclophosphamide;   Biological: E6 TCR;   Drug: AldesleukinSponsor:   National Cancer Institute (NCI)Recruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 30, 2014 Category: Research Source Type: clinical trials

T Cell Receptor Gene Therapy Targeting HPV-16 E6 for HPV-Associated Cancers
Conditions:   Vaginal Cancer;   Cervical Cancer;   Anal Cancer;   Penile Cancer;   Oropharyngeal CancerInterventions:   Drug: Fludarabine;   Drug: Cyclophosphamide;   Biological: E6 TCR;   Drug: AldesleukinSponsor:   National Cancer Institute (NCI)Recruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 30, 2014 Category: Research Source Type: clinical trials

T Cell Receptor Immunotherapy Targeting HPV-16 E6 for HPV-Associated Cancers
Conditions:   Vaginal Cancer;   Cervical Cancer;   Anal Cancer;   Penile Cancer;   Oropharyngeal CancerInterventions:   Drug: Fludarabine;   Drug: Cyclophosphamide;   Biological: E6 TCR;   Drug: AldesleukinSponsor:   National Cancer Institute (NCI)Recruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 30, 2014 Category: Research Source Type: clinical trials